Hollow Crystallization COF Capsuled MOF Hybrids Depict Serum Metabolic Profiling for Precise Early Diagnosis and Risk Stratification of Acute Coronary Syndrome
Advanced Science · 2023
DOI: 10.1002/advs.202302109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Chenjie Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Fudan University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Myocardial Infarction. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shanghai Sailing Program.
Abstract (Originalsprache)
Acute coronary syndrome (ACS), comprising unstable angina (UA) and acute myocardial infarction (AMI), is the leading cause of death worldwide. Currently, lacking effective strategies for classifying ACS hinders the prognosis improvement of ACS patients. Disclosing the nature of metabolic disorders holds the potential to reflect disease progress and high‐throughput mass spectrometry‐based metabolic analysis is a promising tool for large‐scale screening. Herein, a hollow crystallization COF capsuled MOF hybrids (UiO‐66@HCOF) assisted serum metabolic analysis is developed for the early diagnosis and risk stratification of ACS. UiO‐66@HCOF exhibits unrivaled chemical and structural stability as well as endowing satisfying desorption/ionization efficiency in the detection of metabolites. Paired with machine learning algorithms, early diagnosis of ACS is achieved with the area under the curve (AUC) value of 0.945 for validation sets. Besides, a comprehensive ACS risk stratification method is established, and the AUC value for the discrimination of ACS from healthy controls, and AMI from UA are 0.890, and 0.928. Moreover, the AUC value of the subtyping of AMI is 0.964. Finally, the potential biomarkers exhibit high sensitivity and specificity. This study makes metabolic molecular diagnosis a reality and provided new insight into the progress of ACS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Fudan University, Shanghai, 200433, China.
- Department of Cardiology, Shengjing Hospital of China Medical University, NO.36 Sanhao Street, Heping District, Shenyang, 110004, China.
- School of Chemical Science and Technology, Yunnan University, No. 2 North Cuihu Road, Kunming, 650091, P. R. China.
ORCID-Profile: Chunhui Deng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Shanghai Sailing Program
- 345 Talent Project of Shengjing Hospital
Zitieren
APA
Yang, C., Pan, Y., Yu, H., Hu, X., Li, X., & Deng, C. (2023). Hollow Crystallization COF Capsuled MOF Hybrids Depict Serum Metabolic Profiling for Precise Early Diagnosis and Risk Stratification of Acute Coronary Syndrome. Advanced Science. https://doi.org/10.1002/advs.202302109
Vancouver
Yang C, Pan Y, Yu H, Hu X, Li X, Deng C. Hollow Crystallization COF Capsuled MOF Hybrids Depict Serum Metabolic Profiling for Precise Early Diagnosis and Risk Stratification of Acute Coronary Syndrome. Advanced Science. 2023. doi:10.1002/advs.202302109
BibTeX
@article{Yang2023,
author = {Yang, Chenjie and Pan, Yilong and Yu, Hailong and Hu, Xufang and Li, Xiaodong and Deng, Chunhui},
title = {Hollow Crystallization COF Capsuled MOF Hybrids Depict Serum Metabolic Profiling for Precise Early Diagnosis and Risk Stratification of Acute Coronary Syndrome},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202302109}
}
EUVIMED